Target intelligence / Profile preview

Calpain-7 (CAPN7)

Target
CAPN7
Molecular classification
Enzyme, Cysteine protease, Calpain family
01

Overview

Calpain-7 (CAPN7) is a ubiquitously expressed, non-lysosomal, cysteine protease belonging to the calpain family of enzymes[1][2][3]. Structurally, calpains are typically heterodimers with large and small subunits, but Calpain-7 diverges from typical calpains and may function differently from classic calcium-dependent family members[2]. CAPN7 is recruited to the midbody during cell division by binding to the ESCRT-III subunit IST1 via its tandem MIT domains, a process required for efficient completion of cytokinetic abscission and for maintenance of the NoCut checkpoint—a surveillance pathway that delays the final separation of daughter cells in response to mitotic errors[1][3]. CAPN7 thus plays a crucial regulatory role in ensuring proper cell division, acting as a cofactor whose proteolytic activity is modulated by its interactions with ESCRT-III components. In addition to these roles in cytokinesis, CAPN7 is implicated in membrane trafficking processes and may have roles in endosomal sorting, cell migration, and invasion, as well as in reproductive biology where aberrant expression is associated with impaired embryo implantation[3][2]. Its direct physiological substrates in humans have not yet been identified, and no approved drugs are known to target CAPN7 specifically[1][2].

Other names
Calpain-7CAPN7PALBHPalBHpalB homologcalpain-like proteasehomolog of Aspergillus nidulans PALBCALPAIN7calpain-7calpain like proteasehomolog of Aspergillus Nidulans PALB
02

Biological functions

Cytokinetic abscission (completion of cell division)NoCut checkpoint maintenance (delaying cytokinesis in response to mitotic errors)ProteolysisPossible involvement in endosomal sorting and membrane traffickingCell migration and invasion (decidualization of endometrial stromal cells)
03

Disease associations

Neurodegenerative processes (implicated but not comprehensively established)Possible role in embryo implantation/decidualization defectsLimb-girdle muscular dystrophy (associated gene)Congenital disorder of deglycosylation (associated gene)
04

Safety considerations

Unknown substrate specificity, which poses potential risk if therapeutically targeted due to possible effects on multiple cellular pathways

Beyond the preview

Go deeper on Calpain-7 (CAPN7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calpain-7 (CAPN7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call